Results 11 to 20 of about 76,550 (334)

Pericardial Haemangioma: A Common Tumour in an Unusual Location: Case Report and Review of Literature [PDF]

open access: yesJournal of Clinical and Diagnostic Research, 2017
Overall incidence of primary cardiac tumour ranges from 0.0017% and 0.27% at autopsy. Cardiac haemangiomas are rare, and account for 2.8% of benign cardiac tumours. Pericardial haemangiomas, in particular are extremely rare. Pericardial haemangiomas are
Rufus Sam Vargis   +4 more
doaj   +1 more source

A Misleading Left Atrial Appendage

open access: yesJACC: Case Reports, 2023
Left atrial appendage collapse is a relatively unusual echocardiographic finding. Although in post-cardiac surgery patients it may be an early sign of cardiac tamponade, and pericardiocentesis should be discussed, a conservative approach may be followed ...
Alexandros Kourtinos, MD   +3 more
doaj   +1 more source

Long-Term Results after DMEK (Descemet’s Membrane Endothelial Keratoplasty) [PDF]

open access: yes, 2020
Ziel der Arbeit: Evaluation der langfristigen Ergebnisse sowie der Komplikationsrate nach Descemet’s Membran Endothelialen Keratoplastik (DMEK) Methoden: Eine cross-sectional, Fall-Serien Studie.
Wardeh, Rima
core   +1 more source

Cardiac tamponade: an uncommon presenting feature of systemic lupus erythematosus, a case-based review

open access: yesThe Pan African Medical Journal, 2020
Although pericarditis is the most prevalent cardiac involvement in systemic lupus erythematosus (SLE), cardiac tamponade is extremely infrequent notably as the first manifestation of the disease.
Chadia Chourabi   +12 more
doaj   +1 more source

Mediastinal lymphoma-induced superior vena cava syndrome and chylopericardium in a pregnant lady: a case report

open access: yesAvicenna Journal of Medicine, 2020
Mediastinal malignancies are a commonly identified etiology in superior vena cava syndrome (SVCS), and despite the known management of chemotherapy, radiotherapy, or a combination of both, this can prove to be a dilemma during pregnancy.
Omar S Obeidat   +3 more
doaj   +1 more source

Pericardial Effusion With Tamponade in Lung Cancer Patients During Treatment With Nivolumab: A Report of Two Cases

open access: yesFrontiers in Oncology, 2019
Background: Nivolumab is an immune checkpoint inhibitor (ICI) that has shown efficacy for treating non-small cell lung cancer and has become a standard therapy for previously treated non-small cell lung cancer.
Masahiro Yamasaki   +11 more
doaj   +1 more source

Mediastinal debulking for a T-cell leukaemia/lymphoma presenting with cardiac tamponade

open access: yesMonaldi Archives for Chest Disease, 2019
Anterior mediastinal masses are relatively uncommon and include a wide variety of lesions. Lymphomas account for 25% of anterior mediastinal masses. Lymphomas and other haematological malignancies are associated with pericardial effusion.
Sotirios D. Moraitis   +6 more
doaj   +1 more source

Tamponade and massive pleural effusions secondary to peripherally inserted central catheter in neonates–A complication to be aware of

open access: yesFrontiers in Cardiovascular Medicine, 2023
BackgroundPeripherally inserted central catheters (PICC) are frequently used in neonatal intensive care units (NICU) to assist premature and critically ill neonates.
Rana Zareef   +11 more
doaj   +1 more source

Refractive change following pseudophakic vitrectomy: a retrospective review [PDF]

open access: yes, 2008
Background To assess the occurrence and magnitude of refractive change in pseudophakic eyes undergoing 20 gauge pars plana vitrectomy without scleral buckling and to investigate possible aetiological factors.
Anthony Hildreth   +19 more
core   +5 more sources

History of the Innovation of Damage Control for Management of Trauma Patients: 1902-2016 [PDF]

open access: yes, 2017
Objective: To review the history of the innovation of damage control (DC) for management of trauma patients. Background: DC is an important development in trauma care that provides a valuable case study in surgical innovation.
Ball, Chad G.   +9 more
core   +3 more sources

Home - About - Disclaimer - Privacy